Items related to Inflammatory Bowel Disease Update: Pathogenesis, Diagnosis...
IBD is a lifelong disease with periods of active disease alternating with periods of remission. IBD is thought to result from the interaction between genetic and environmental factors that influence the normal intestinal commensal flora to trigger an inappropriate mucosal immune response. Colonoscopy remains the gold stander for diagnosis of IBD. Wireless capsule endoscope and balloon enteroscopy show many advances in diagnosis of IBD. CT and MRI help to detect extent of disease and assess complications. Serological and fecal markers alone can not establish diagnosis of IBD but they have only a prognostic value. 5-ASA agents are the mainstay in the treatment of both CD and UC. Steroids continue to be the first choice to treat active disease. 6-mercaptopurine and azathioprine are steroid-sparing immunomodulators effective in the maintenance of remission of both CD and UC while methotrexate may be used in both induction and maintenance of CD. Infliximab and adalimumab are anti-TNF agents approved for the treatment of CD and UC. Other new emerging therapies include antibiotics, prebiotics, probiotics, leucocyte apheresis, Interferon-alpha and helminth.
"synopsis" may belong to another edition of this title.
About the Author:
Dr. Ahmed sharaf has obtained his master degree in tropical medicine in 2011. Since then he has worked as assistant lecturer in Tropical Medicine Department, Faculty Of Medicine, Zagazig University.
"About this title" may belong to another edition of this title.
- PublisherLAP LAMBERT Academic Publishing
- Publication date2012
- ISBN 10 3847334433
- ISBN 13 9783847334439
- BindingPaperback
- Number of pages152
Buy New
Learn more about this copy
US$ 60.62
Shipping:
US$ 3.99
Within U.S.A.
Top Search Results from the AbeBooks Marketplace
Stock Image
Inflammatory Bowel Disease Update: Pathogenesis, Diagnosis And Treatment
Published by
LAP LAMBERT Academic Publishing
(2012)
ISBN 10: 3847334433
ISBN 13: 9783847334439
New
Softcover
Quantity: 18
Seller:
Rating
Book Description Condition: New. Seller Inventory # ABLIING23Apr0316110136354
Buy New
US$ 60.62
Convert currency
Stock Image
Inflammatory Bowel Disease Update
Published by
LAP Lambert Academic Publishing
(2012)
ISBN 10: 3847334433
ISBN 13: 9783847334439
New
Softcover
Quantity: > 20
Seller:
Rating
Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9783847334439_lsuk
Buy New
US$ 67.24
Convert currency
Stock Image
Inflammatory Bowel Disease Update
Published by
LAP Lambert Academic Publishing 2012-01
(2012)
ISBN 10: 3847334433
ISBN 13: 9783847334439
New
PF
Quantity: 10
Seller:
Rating
Book Description PF. Condition: New. Seller Inventory # 6666-IUK-9783847334439
Buy New
US$ 64.11
Convert currency
Stock Image
Inflammatory Bowel Disease Update Pathogenesis, Diagnosis And Treatment
Published by
LAP LAMBERT Academic Publishing
(2012)
ISBN 10: 3847334433
ISBN 13: 9783847334439
New
PAP
Quantity: > 20
Seller:
Rating
Book Description PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9783847334439
Buy New
US$ 87.15
Convert currency
Seller Image
Inflammatory Bowel Disease Update
Published by
LAP Lambert Academic Publishing
(2012)
ISBN 10: 3847334433
ISBN 13: 9783847334439
New
Taschenbuch
Quantity: 2
Seller:
Rating
Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -IBD is a lifelong disease with periods of active disease alternating with periods of remission. IBD is thought to result from the interaction between genetic and environmental factors that influence the normal intestinal commensal flora to trigger an inappropriate mucosal immune response. Colonoscopy remains the gold stander for diagnosis of IBD. Wireless capsule endoscope and balloon enteroscopy show many advances in diagnosis of IBD. CT and MRI help to detect extent of disease and assess complications. Serological and fecal markers alone can not establish diagnosis of IBD but they have only a prognostic value. 5-ASA agents are the mainstay in the treatment of both CD and UC. Steroids continue to be the first choice to treat active disease. 6-mercaptopurine and azathioprine are steroid-sparing immunomodulators effective in the maintenance of remission of both CD and UC while methotrexate may be used in both induction and maintenance of CD. Infliximab and adalimumab are anti-TNF agents approved for the treatment of CD and UC. Other new emerging therapies include antibiotics, prebiotics, probiotics, leucocyte apheresis, Interferon-alpha and helminth. 152 pp. Englisch. Seller Inventory # 9783847334439
Buy New
US$ 66.17
Convert currency
Stock Image
Inflammatory Bowel Disease Update Pathogenesis, Diagnosis And Treatment
Published by
LAP LAMBERT Academic Publishing
(2012)
ISBN 10: 3847334433
ISBN 13: 9783847334439
New
PAP
Quantity: > 20
Seller:
Rating
Book Description PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9783847334439
Buy New
US$ 71.00
Convert currency
Seller Image
Inflammatory Bowel Disease Update : Pathogenesis, Diagnosis And Treatment
Published by
LAP Lambert Academic Publishing
(2012)
ISBN 10: 3847334433
ISBN 13: 9783847334439
New
Taschenbuch
Quantity: 2
Seller:
Rating
Book Description Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - IBD is a lifelong disease with periods of active disease alternating with periods of remission. IBD is thought to result from the interaction between genetic and environmental factors that influence the normal intestinal commensal flora to trigger an inappropriate mucosal immune response. Colonoscopy remains the gold stander for diagnosis of IBD. Wireless capsule endoscope and balloon enteroscopy show many advances in diagnosis of IBD. CT and MRI help to detect extent of disease and assess complications. Serological and fecal markers alone can not establish diagnosis of IBD but they have only a prognostic value. 5-ASA agents are the mainstay in the treatment of both CD and UC. Steroids continue to be the first choice to treat active disease. 6-mercaptopurine and azathioprine are steroid-sparing immunomodulators effective in the maintenance of remission of both CD and UC while methotrexate may be used in both induction and maintenance of CD. Infliximab and adalimumab are anti-TNF agents approved for the treatment of CD and UC. Other new emerging therapies include antibiotics, prebiotics, probiotics, leucocyte apheresis, Interferon-alpha and helminth. Seller Inventory # 9783847334439
Buy New
US$ 66.97
Convert currency
Seller Image
Inflammatory Bowel Disease Update
Published by
LAP LAMBERT Academic Publishing
(2012)
ISBN 10: 3847334433
ISBN 13: 9783847334439
New
Kartoniert / Broschiert
Quantity: > 20
Seller:
Rating
Book Description Kartoniert / Broschiert. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: sharaf ahmedDr. Ahmed sharaf has obtained his master degree in tropical medicine in 2011. Since then he has worked as assistant lecturer in Tropical Medicine Department, Faculty Of Medicine, Zagazig University.IBD is a lifelong d. Seller Inventory # 5510779
Buy New
US$ 55.25
Convert currency